Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 7,065 | 6,856 | 4,635 | 3,426 | 2,687 |
| Gross Profit | 7,065 | 6,856 | 4,635 | 3,426 | 2,687 |
| Operating Expenses | 25,961 | 22,281 | 20,056 | 15,903 | 15,083 |
| Operating Income | -18,896 | -15,425 | -15,421 | -12,477 | -12,396 |
| Interest Expense | 129 | 140 | 161 | 171 | 179 |
| Other Income | 131 | 61 | 7 | 6 | -405 |
| Pre-tax Income | -18,894 | -15,504 | -15,575 | -12,642 | -12,980 |
| Net Income Continuous | -18,894 | -15,504 | -15,575 | -12,642 | -12,980 |
| Net Income | $-18,894 | $-15,504 | $-15,575 | $-12,642 | $-12,980 |
| EPS Basic Total Ops | -0.70 | -0.57 | 6.44 | -0.47 | -0.81 |
| EPS Basic Continuous Ops | -0.70 | -0.57 | 5.22 | -0.47 | -0.76 |
| EPS Diluted Total Ops | -0.70 | -0.57 | 6.44 | -0.47 | -0.81 |
| EPS Diluted Continuous Ops | -0.70 | -0.57 | 5.22 | -0.47 | -0.76 |
| EBITDA(a) | $-18,425 | $-15,004 | $-15,088 | $-12,273 | $-12,194 |